Delivery Order SPE2DB24D1007-SPE2DB25FB5PX
- Not listed
- The Defense Logistics Agency awarded a $124,402.18 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion date of November 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $51,605.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, non-set-aside contract was awarded on July 10, 2025, with an ultimate completion date of July 31, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 12, 2025, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $15,481.50 delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents, with an ultimate completion date of November 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside firm fixed price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The vaccine will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,064.22 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, designated as a firm fixed price delivery order, was competitively awarded without a set-aside provision and is scheduled for completion by August 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $2,105.92 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with a completion date of June 17, 2025. This firm fixed-price delivery order represents a non-competitive procurement issued under the company's existing contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $5,264.80 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded with no set-aside designation and features firm fixed price pricing. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,106.02 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 3, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FB5PXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that serves as the primary global sourcing mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products including vaccines, specialty medications, and medical supplies across multiple therapeutic domains. This Varivax delivery order represents a discrete vaccine procurement supporting military healthcare requirements through DLA's established pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/18/25 |